O=[N+]([O-])c1ccc(/C=N/n2c(S)nnc2CCc2nnc(S)n2/N=C/c2ccc([N+](=O)[O-])o2)o1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?